UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study

Diabetes, obesity & metabolism, 2011-11, Vol.13 (11), p.982-989

2011

Volltextzugriff (PDF)

Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities

Diabetic medicine, 2009-01, Vol.26 (1), p.61-69

2009

Volltextzugriff (PDF)

Pharmacokinetic and glucodynamic comparisons of recombinant and animal‐source glucagon after IV, IM, and SC injection in healthy volunteers

Journal of pharmaceutical sciences, 1999-10, Vol.88 (10), p.991-995

1999

Volltextzugriff (PDF)

Insulin lispro lowers postprandial glucose in prepubertal children with diabetes

Pediatrics (Evanston), 2001-11, Vol.108 (5), p.1175-1179

2001

Volltextzugriff (PDF)

Serum growth hormone (GH)-binding protein/receptor : an important determinant of GH responsiveness

The journal of clinical endocrinology and metabolism, 1992-12, Vol.75 (6), p.1464-1469

1992

Volltextzugriff (PDF)

Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus

The journal of clinical endocrinology and metabolism, 1997-03, Vol.82 (3), p.920-924

1997

Volltextzugriff (PDF)

A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump

Journal of diabetes and its complications, 2001-11, Vol.15 (6), p.295-300

2001

Volltextzugriff (PDF)

The role of body mass in the response to growth hormone therapy

The journal of clinical endocrinology and metabolism, 1992-12, Vol.75 (6), p.1470-1473

1992

Volltextzugriff (PDF)

Patient and physician satisfaction with the Humulin ®/Humalog ® Pen, a new 3.0-mL prefilled pen device for insulin delivery

Clinical therapeutics, 2000-09, Vol.22 (9), p.1049-1067

2000

Volltextzugriff (PDF)

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data

International journal of geriatric psychiatry, 2001-12, Vol.16 (S1), p.S33-S61

2001

Volltextzugriff (PDF)

Approaching final height in children treated for growth hormone deficiency

Hormone research, 1995, Vol.43 (4), p.129-131

1995

Volltextzugriff (PDF)

Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

Clinical therapeutics, 2004-12, Vol.26 (12), p.2034-2044

2004

Volltextzugriff (PDF)

Sravnenie kombinatsiy insulina lizpromiks 25 s metforminom i insulina glarginas metforminom pri lechenii patsientovs sakharnym diabetom 2 tipa,ranee ne poluchavshikh insulinoterapii(16-nedel'noe randomizirovannoe otkrytoeperekrestnoe issledovanie)

Sakharnyĭ diabet, 2006-06, Vol.9 (2), p.41-49

2006

Volltextzugriff (PDF)

Mixing insulin lispro and ultralente insulin

Diabetes care, 1997-06, Vol.20 (6), p.1047-1048

1997

Volltextzugriff (PDF)

Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease

Pediatric research, 1984-09, Vol.18 (9), p.864-870

1984

Volltextzugriff (PDF)

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents

Clinical therapeutics, 2002-04, Vol.24 (4), p.629-638

2002

Volltextzugriff (PDF)

Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia

Pediatrics (Evanston), 1980-04, Vol.65 (4), p.777-781

1980

Volltextzugriff (PDF)

Sodium homeostasis and aldosterone secretion in salt-losing congenital adrenal hyperplasia

The journal of clinical endocrinology and metabolism, 1979-03, Vol.48 (3), p.430-436

1979

Volltextzugriff (PDF)

How long should insulin be used once a vial is started?

Diabetes care, 2003-09, Vol.26 (9), p.2665-2669

2003

Volltextzugriff (PDF)

Case Report: Plasma Lipids and Apolipoproteins in a 13-Year-Old Boy with Diabetic Ketoacidosis and Extreme Hyperlipidemia

The American journal of the medical sciences, 1986-05, Vol.291 (5), p.342-346

1986

Volltextzugriff (PDF)

How Long Should Insulin Be Used Once a Vial Is Started?

Diabetes care, 2004-05, Vol.27 (5), p.1241-1242

2004

Volltextzugriff (PDF)

Biosynthetic human growth hormone in the treatment of growth hormone deficiency

Acta pædiatrica Scandinavica. Supplement, 1990, Vol.367, p.44

1990

Volltextzugriff (PDF)

Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses

The journal of clinical endocrinology and metabolism, 1980-08, Vol.51 (2), p.223-229

1980

Volltextzugriff (PDF)

Unterschiedlicher Einfluss von Exenatide und Insulin Glargin auf die postprandialen Blutzuckerspitzen bei Typ 2 Diabetes

Diabetologie und Stoffwechsel, 2006, Vol.1 (S 1)

2006

Volltextzugriff (PDF)

Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression

The Journal of laboratory and clinical medicine, 1979-11, Vol.94 (5), p.799

1979

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(197)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(244)
Japanisch
(27)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study

Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities

Pharmacokinetic and glucodynamic comparisons of recombinant and animal‐source glucagon after IV, IM, and SC injection in healthy volunteers

Insulin lispro lowers postprandial glucose in prepubertal children with diabetes

Serum growth hormone (GH)-binding protein/receptor : an important determinant of GH responsiveness

Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus

A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump

The role of body mass in the response to growth hormone therapy

Patient and physician satisfaction with the Humulin ®/Humalog ® Pen, a new 3.0-mL prefilled pen device for insulin delivery

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data

Approaching final height in children treated for growth hormone deficiency

Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

Sravnenie kombinatsiy insulina lizpromiks 25 s metforminom i insulina glarginas metforminom pri lechenii patsientovs sakharnym diabetom 2 tipa,ranee ne poluchavshikh insulinoterapii(16-nedel'noe randomizirovannoe otkrytoeperekrestnoe issledovanie)

Mixing insulin lispro and ultralente insulin

Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents

Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia

Sodium homeostasis and aldosterone secretion in salt-losing congenital adrenal hyperplasia

How long should insulin be used once a vial is started?

Case Report: Plasma Lipids and Apolipoproteins in a 13-Year-Old Boy with Diabetic Ketoacidosis and Extreme Hyperlipidemia

How Long Should Insulin Be Used Once a Vial Is Started?

Biosynthetic human growth hormone in the treatment of growth hormone deficiency

Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses

Unterschiedlicher Einfluss von Exenatide und Insulin Glargin auf die postprandialen Blutzuckerspitzen bei Typ 2 Diabetes

Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression

Aktive Filter

Suchergebnisse filtern